***ZAKONOWO POLOZENIE***
V Bulgaria marihuanata e poso4ena v spisak #1 na Zakona za
kontrol varhu narkoti4nite ve6testva i prekursorite. V tozi
spisak sa izbroeni ve6testva, koito spored balgarskia
zakonodatel sa zabraneni za upotreba v humannata i
veterinarnata medicina. V tozi spisak e i heroina.
Pridobivaneto ili darzaneto na koeto i da e bilo ot ve6testvata v
tozi spisak s ogled na 4L. 354a ot Nakazatelnia Kodeks se
nakazva s li6avane ot svoboda ot 1 do 6 godini i s globa ot
2 000 do 10 000 leva. Proizvodstvoto, prerabotvaneto,
pridobivaneto ili darzaneto s cel razprostranenie
se nakazva s li6avane ot svoboda ot 2 do 8 godini i s globa ot
5 000 do 20 000 leva. Kogato narkoti4nite ve6testva sa v
goliamo koli4estvo, nakazanieto e li6avane ot svoboda ot 3 do
12 godini i globa ot 10 000 do 50 000 leva.
***UMNATA MANIACI***
MEDICAL CANNABIS HISTORY
Cannabis has been used for medicinal purposes for over 4,800 years. Surviving texts from Ancient India confirm that its psychoactive properties were recognized, and doctors used it for a variety of illnesses and ailments. These included a whole host of gastrointestinal disorders, insomnia, headaches and as a pain reliever, frequently used in childbirth. Cannabis as a medicine was common throughout most of the world in the 1800s. It was used as the primary pain reliever until the invention of aspirin. Modern medical and scientific inquiry began with doctors like O'Shaughnessy and Moreau de Tours, who used it to treat melancholia, migraines, and as a sleeping aid, analgesic and anticonvulsant. By the time the ....United States.... banned cannabis (the third country to do so) with the 1937 Marijuana Tax Act, the plant was no longer extremely popular. Skepticism about marijuana arose in response to the bill. One of the main opponents to the bill was the representative of the American Medical Association. Later in the century, researchers investigating methods of detecting cannabis intoxication discovered that smoking the drug reduced intraocular pressure. High intraocular pressure causes blindness in glaucoma patients, so many believed that using the drug could prevent blindness in patients. Many Vietnam War veterans also believed that the drug prevented muscle spasms caused by battle-induced spinal injuries. Later medical use has focused primarily on its role in preventing the wasting syndromes and chronic loss of appetite associated with chemotherapy and AIDS, along with a variety of rare muscular and skeletal disorders. Less commonly, cannabis has been used in the treatment of alcoholism and addiction to other drugs such as heroin and the prevention of migraines. In recent years, studies have shown or researchers have speculated that the main chemical in the drug, THC, might help prevent atherosclerosis. In 1972 Tod H. Mikuriya, M.D. reignited the debate concerning marijuana as medicine when he published "Marijuana Medical Papers 1839-1972". Later, in the 1970s, a synthetic version of THC, the primary active ingredient in cannabis, was synthesized to make the drug Marinol. Users reported several problems with Marinol, however, that led many to abandon the pill and resume smoking the plant. Patients complained that the violent nausea associated with chemotherapy made swallowing pills difficult. The effects of smoked cannabis are felt almost immediately, and is therefore easily dosed. Marinol (Dronabinol), like ingested cannabis, is very psychoactive, and is harder to titrate than smoked cannabis. Marinol has also consistently been more expensive than herbal cannabis. Some studies have indicated that other chemicals in the plant may have a synergistic effect with THC. In addition, during the 1970s and 1980s, six US states' health departments performed studies on the use of medical marijuana. These are widely considered some of the most useful and pioneering studies on the subject. In May 2001, "The Chronic Cannabis Use in the Compassionate Investigational New Drug Program: An Examination of Benefits and Adverse Effects of Legal Clinical Cannabis" (Russo, Mathre, Byrne et al) was completed. This three-day examination of major body functions of four of the five living US federal cannabis patients found "mild pulmonary changes" in two patients.